簡易檢索 / 詳目顯示

研究生: 黃湘琳
Huang, Hsiang-Lin
論文名稱: 合成金銅修飾的鐵鉑奈米立方體作為癌症化學動力治療
Synthesis of FePt@Au/Cu0 Nanocubes for Chemodynamic Therapy as Cancer Treatment
指導教授: 葉晨聖
Yeh, Chen-Sheng
學位類別: 碩士
Master
系所名稱: 理學院 - 化學系
Department of Chemistry
論文出版年: 2024
畢業學年度: 112
語文別: 中文
論文頁數: 122
中文關鍵詞: 零價銅化學動力治療晶格應變單原子催化劑生物可降解性
外文關鍵詞: Zero-valent Copper, Chemodynamic therapy, Lattice strain, Single-atom catalysts, Biodegradable material
相關次數: 點閱:59下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 隨著癌症罹患人數不斷增加,癌症治療一直是熱門的研究領域。化學動力治療是一應用於癌症治療的方法,透過產生對腫瘤細胞有毒性的活性氧物質以治療癌症,然而化學動力治療仍面臨內源性雙氧水不足的問題,無法提供充足的雙氧水以進行芬頓反應。因此,本研究設計了具有晶格應變 (Lattice strain) 與單原子催化 (Single-atom catalyst) 的FePt@Au/Cu,透過晶格應變與單原子催化促進FePt@Au/Cu產生過氧化氫,以增強化學動力治療效果。
    首先合成出FePt@Cu為零價銅,透過加凡尼取代反應合成出FePt@Au/Cu,並於其表面修飾硬脂酸合成出FePt@Au/Cu@SA,以避免材料提早與氧氣反應;透過包吞作用進入目標細胞後,硬脂酸可與細胞膜融合釋放出FePt@Au/Cu,降解釋放銅離子與電子 (Cu → Cu+ + e- → Cu2+ + e-),氧氣接受電子還原成過氧化氫 (O2 + 2H+ + 2e- → H2O2),過氧化氫再與銅離子透過類芬頓反應 (Fenton-like reaction) 產生羥基自由基 (Cu+ + H2O2 → Cu2+ + •OH + -OH)。而FePt@Au/Cu之晶格應變、比表面積以及單原子催化,皆進行相關實驗予以佐證上述因素促進了FePt@Au/Cu能產生更多過氧化氫,提升化學動力治療的效果。實驗結果證實,FePt@Au/Cu生成•OH的反應效率最好。DFT計算結果表明,在FePt@Au/Cu上O2兩次被氫化 (O2(a) → OOH, OOH(a) → H2O2) 的活化能 (0.73 eV, 0.65 eV) 均比 Cu (1.02 eV, 0.91 eV)、FePt@Cu (0.97 eV, 0.97 eV) 低,因此FePt@Au/Cu相較於Cu、FePt@Cu具有更快的H2O2生成速率,使FePt@Au/Cu具有更好的化學動力學治療療效。此外,FePt@Au/Cu@SA具有生物可降解特性,可透過尿液代謝方式排出於體外,避免材料累積於生物體內。

    Chemodynamic therapy (CDT) is a method used for cancer treatment but limited by insufficient endogenous hydrogen peroxide. Hence, we provide a degradable gold-copper-modified iron-platinum nanocubes (FePt@Au/Cu) with lattice strain and single-atom catalyst, which had excellent cascade oxidase-like and Fenton-like catalytic reactivity. With stearic acid (SA) modification, FePt@Au/Cu@SA can enter cancer cell through endocytosis, SA could fuse with the cell membrane to release FePt@Au/Cu, when FePt@Au/Cu decomposed, it could release Cu+ and e-, reduced O2 to form H2O2, then generated •OH by Fenton-like reaction. FePt@Au/Cu had better catalytic reactivity than Cu or FePt@Cu. Besides, FePt@Au/Cu was a biodegradable material, could be excreted from the body through urine metabolism to avoid accumulation of materials.

    摘要 I 英文延伸摘要 (Extended Abstract) II 誌謝 XII 目錄 XIII 表目錄 XVII 圖目錄 XVIII 第一章 緒論 1 1-1 前言 1 1-2 化學動力治療 (Chemodynamic Therapy) 2 1-2-1 化學動力治療的優勢與限制 3 1-2-2 自產雙氧水 (Self-supplying H2O2) 5 1-2-3 類氧化酶催化(Oxidase-like Catalysis)產生H2O2 15 1-2-4 零價銅 (Zero-valent Copper, ZVC) 19 1-3 晶格應變 (Lattice Strain) 21 1-4 單原子催化劑 (Single-atom Catalysts) 26 1-4-1 調控單原子催化 30 1-4-2 單原子輔助催化之實例 34 1-5 加凡尼取代反應 (Galvanic Replacement Reaction) 37 1-6 奈米材料生物可降解 (Biodegradable) 特性 40 第二章 實驗藥品與儀器 43 2-1 奈米材料合成與鑑定所需藥品 43 2-2 細胞實驗相關藥品 44 2-3 細胞株 45 2-4 實驗儀器 45 第三章 研究動機與實驗方法 47 3-1 研究動機 47 3-2 實驗方法 50 3-2-1 鐵鉑奈米粒子的合成 (FePt NPs) 50 3-2-2 銅奈米立方體的製備 (Cu NCs) 50 3-2-3 銅修飾FePt NPs的製備 (FePt@Cu NCs) 51 3-2-4 金銅修飾鐵鉑奈米立方體的製備 (FePt@Au/Cu NCs) 52 3-2-5 FePt@Au/Cu表面修飾硬脂酸 (Stearic acid, SA) (FePt@Au/Cu@SA) 53 3-2-6 過氧化氫 (H2O2) 生成之檢測 54 3-2-6-1 不同材料之過氧化氫生成 54 3-2-6-2 不同濃度FePt@Au/Cu在絕氧環境之過氧化氫生成 54 3-2-7 羥基自由基 (•OH) 生成之檢測 54 3-2-7-1 Disodium terephthalate (TPA)螢光偵測 55 3-2-8 穩定性實驗 55 3-2-9 細胞培養 56 3-2-10 細胞毒性測試 (MTT-assay) 56 3-2-11 細胞相容性之溶血實驗分析(Hemolysis) 57 3-2-12 細胞螢光影像 (Confocal Images) 58 3-2-12-1 活死細胞螢光影像(Live/Dead) 58 3-2-12-2 Cu+, H2O2, •OH生成之螢光影像 59 3-2-13 FePt@Au/Cu@SA之生物分布 60 3-2-14 DFT計算方法 60 第四章 結果與討論 61 4-1 材料的結構與性質鑑定 61 4-1-1 鐵鉑奈米粒子 (FePt NPs) 61 4-1-2 銅奈米立方體 (Cu NCs) 61 4-1-3 銅修飾鐵鉑奈米立方體 (FePt@Cu NCs) 62 4-1-4 金銅修飾鐵鉑奈米立方體的製備 (FePt@Au/Cu NCs) 62 4-1-5 過氧化氫 (H2O2) 生成之鑑定 66 4-1-5-1 不同材料之過氧化氫生成 66 4-1-5-2 不同濃度FePt@Au/Cu在絕氧環境之過氧化氫生成 67 4-1-6 羥基自由基 (•OH) 生成之鑑定 68 4-1-6-1 Disodium terephthalate (TPA)螢光偵測 68 4-1-7 提升催化能力之因素 69 4-1-7-1 晶格應變 (Lattice strain) 69 4-1-7-2 比表面積 71 4-1-7-3 單原子催化 (Single-atom catalyst) 72 4-2 理論計算 72 4-3 FePt@Au/Cu穩定性實驗 76 4-4 FePt@Au/Cu表面修飾硬脂酸 (SA) (FePt@Au/Cu@SA) 78 4-4-1 材料的結構與性質鑑定 78 4-4-2 FePt@Au/Cu@SA穩定性之測定 79 4-4-3 細胞相容性之溶血實驗分析(Hemolysis) 80 4-5 細胞毒性測試 (MTT-assay) 81 4-6 細胞螢光影像 (Confocal Images) 82 4-7 材料之生物分布 84 4-8 討論 85 第五章 結論 87 參考文獻 88

    1. Ni, K., G. Lan, and W. Lin, Nanoscale metal–organic frameworks generate reactive oxygen species for cancer therapy. ACS central science, 2020, 6(6), 861-868.
    2. Zhang, C., et al., Reactive oxygen species‐regulating strategies based on nanomaterials for disease treatment. Advanced Science, 2021, 8(3), 2002797.
    3. Trachootham, D., J. Alexandre, and P. Huang, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov, 2009, 8(7), 579-91.
    4. Glasauer, A. and N.S. Chandel, Targeting antioxidants for cancer therapy. Biochem Pharmacol, 2014, 92(1), 90-101.
    5. Wang, N., et al., Eradication of solid tumors by chemodynamic theranostics with H2O2-catalyzed hydroxyl radical burst. Theranostics, 2021, 11(5), 2334-2348.
    6. He, T., et al., Tumor pH-responsive metastable-phase manganese sulfide nanotheranostics for traceable hydrogen sulfide gas therapy primed chemodynamic therapy. Theranostics, 2020, 10(6), 2453-2462.
    7. Luo, B., et al., A simple and feasible atom-precise biotinylated Cu(I) complex for tumor-targeted chemodynamic therapy. Chem Commun (Camb), 2021, 57(49), 6046-6049.
    8. Zhou, Z., et al., Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chemical society reviews, 2016, 45(23), 6597-6626.
    9. Chen, W., et al., Research progress on improving the efficiency of CDT by exacerbating tumor acidification. International Journal of Nanomedicine, 2022, 2611-2628.
    10. Tian, Q., et al., Recent advances in enhanced chemodynamic therapy strategies. Nano Today, 2021, 39, 101162.
    11. Wang, T., et al., Boosting H2O2‐guided chemodynamic therapy of cancer by enhancing reaction kinetics through versatile biomimetic fenton nanocatalysts and the second near‐infrared light irradiation. Advanced Functional Materials, 2020, 30(3), 1906128.
    12. Ma, B., et al., Self-assembled copper–amino acid nanoparticles for in situ glutathione “AND” H2O2 sequentially triggered chemodynamic therapy. Journal of the American Chemical Society, 2018, 141(2), 849-857.
    13. Lin, L.-S., et al., Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy. Journal of the American Chemical Society, 2019, 141(25), 9937-9945.
    14. He, Y.-J., et al., Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator. Biomaterials, 2020, 241, 119911.
    15. Zhang, C., et al., Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction. Angewandte Chemie International Edition, 2016, 55(6), 2101-2106.
    16. Fenton, H.J.H., LXXIII.—Oxidation of tartaric acid in presence of iron. Journal of the Chemical Society, Transactions, 1894, 65, 899-910.
    17. Pignatello, J.J., E. Oliveros, and A. MacKay, Advanced oxidation processes for organic contaminant destruction based on the Fenton reaction and related chemistry. Critical reviews in environmental science and technology, 2006, 36(1), 1-84.
    18. Haber, F. and J. Weiss, The catalytic decomposition of hydrogen peroxide by iron salts. Proceedings of the Royal Society of London. Series A-Mathematical and Physical Sciences, 1934, 147(861), 332-351.
    19. Barb, W., et al., Reactions of ferrous and ferric ions with hydrogen peroxide. Part II.—The ferric ion reaction. Transactions of the Faraday Society, 1951, 47, 591-616.
    20. Stanbury, D.M., The principle of detailed balancing, the iron-catalyzed disproportionation of hydrogen peroxide, and the Fenton reaction. Dalton Transactions, 2022, 51(6), 2135-2157.
    21. Jia, C., Y. Guo, and F.G. Wu, Chemodynamic therapy via fenton and fenton‐like nanomaterials: strategies and recent advances. Small, 2022, 18(6), 2103868.
    22. Yang, B., Y. Chen, and J. Shi, Reactive oxygen species (ROS)-based nanomedicine. Chemical reviews, 2019, 119(8), 4881-4985.
    23. Cao, C., et al., Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry. Chemical Science, 2022, 13(4), 863-889.
    24. Zhou, Y., et al., Manipulating intratumoral fenton chemistry for enhanced chemodynamic and chemodynamic‐synergized multimodal therapy. Advanced Materials, 2021, 33(48), 2104223.
    25. Wang, X., et al., Recent progress of chemodynamic therapy-induced combination cancer therapy. Nano Today, 2020, 35, 100946.
    26. Xie, W., et al., TME-responded Full-biodegradable nanocatalyst for mitochondrial calcium Overload-induced hydroxyl radical bursting cancer treatment. Chemical Engineering Journal, 2022, 438, 135372.
    27. Song, X., et al., Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer. Nano letters, 2018, 18(10), 6360-6368.
    28. Huo, M., et al., Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nature communications, 2017, 8(1), 357.
    29. Liu, C., et al., An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy. Nature communications, 2020, 11(1), 1735.
    30. Li, W.-P., et al., Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome. ACS nano, 2016, 10(2), 2017-2027.
    31. Choi, J., et al., Fabrication of oxygen releasing scaffold by embedding H2O2-PLGA microspheres into alginate-based hydrogel sponge and its application for wound healing. Applied Sciences, 2018, 8(9), 1492.
    32. Lin, L.-S., et al., Cooperation of endogenous and exogenous reactive oxygen species induced by zinc peroxide nanoparticles to enhance oxidative stress-based cancer therapy. Theranostics, 2019, 9(24), 7200.
    33. Han, Y., et al., Engineering H2O2 self-supplying nanotheranostic platform for targeted and imaging-guided chemodynamic therapy. ACS applied materials & interfaces, 2019, 12(1), 288-297.
    34. Feng, L., et al., Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation. ACS nano, 2018, 12(11), 11000-11012.
    35. Liu, Y., et al., Glucose Oxidase-Modified Metal–Organic Framework for Starving-Enhanced Chemodynamic Therapy. ACS Applied Bio Materials, 2023, 6(2), 857-864.
    36. Yang, Y., et al., Iridium Oxide-Doped Calcium Phosphate Nanoparticles for Chemodynamic Therapy of Cancer. ACS Applied Nano Materials, 2023.
    37. Huang, Y., J. Ren, and X. Qu, Nanozymes: classification, catalytic mechanisms, activity regulation, and applications. Chemical reviews, 2019, 119(6), 4357-4412.
    38. Wang, D., et al., Self‐assembled single‐site nanozyme for tumor‐specific amplified cascade enzymatic therapy. Angewandte Chemie, 2021, 133(6), 3038-3044.
    39. Gao, S., et al., Nanocatalytic tumor therapy by biomimetic dual inorganic nanozyme‐catalyzed cascade reaction. Advanced Science, 2019, 6(3), 1801733.
    40. Liu, J., et al., Metal Site and Size-Controlled BTC-Based MOF as Cysteine Oxidase Mimic for Self-Cascade Detection of Cysteine and Hg2+. The Journal of Physical Chemistry B, 2023, 127(44), 9513-9519.
    41. Pi, L., et al., Generation of H2O2 by on-site activation of molecular dioxygen for environmental remediation applications: A review. Chemical Engineering Journal, 2020, 389, 123420.
    42. Dong, G., Z. Ai, and L. Zhang, Total aerobic destruction of azo contaminants with nanoscale zero-valent copper at neutral pH: promotion effect of in-situ generated carbon center radicals. Water research, 2014, 66, 22-30.
    43. Gabrys, P.A., et al., Lattice mismatch in crystalline nanoparticle thin films. Nano letters, 2018, 18(1), 579-585.
    44. Kim, H.-S. and N.-G. Park, Importance of tailoring lattice strain in halide perovskite crystals. NPG Asia Materials, 2020, 12(1), 78.
    45. Broberg, D., et al., PyCDT: A Python toolkit for modeling point defects in semiconductors and insulators. Computer Physics Communications, 2018, 226, 165-179.
    46. Wu, C.-S., et al., Effect of atomic size difference on the microstructure and mechanical properties of high-entropy alloys. Entropy, 2018, 20(12), 967.
    47. Zhao, J., et al., Strained hybrid perovskite thin films and their impact on the intrinsic stability of perovskite solar cells. Science advances, 2017, 3(11), eaao5616.
    48. Jacobsson, T.J., et al., Determination of thermal expansion coefficients and locating the temperature-induced phase transition in methylammonium lead perovskites using x-ray diffraction. Inorganic chemistry, 2015, 54(22), 10678-10685.
    49. Craciun, V., et al., Transparent and conducting indium tin oxide thin films grown by pulsed laser deposition at low temperatures. J. Optoelectron. Adv. Mater, 2003, 5, 401-408.
    50. Wang, Y., et al., Lattice‐strain engineering of homogeneous NiS0. 5Se0. 5 core–shell nanostructure as a highly efficient and robust electrocatalyst for overall water splitting. Advanced Materials, 2020, 32(40), 2000231.
    51. Wei, Z., et al., Enhancing Selective Electrochemical CO2 Reduction by In Situ Constructing Tensile-Strained Cu Catalysts. ACS Catalysis, 2023, 13(7), 4711-4718.
    52. Yang, X.-F., et al., Single-atom catalysts: a new frontier in heterogeneous catalysis. Accounts of chemical research, 2013, 46(8), 1740-1748.
    53. Liu, J., Catalysis by supported single metal atoms. Acs Catalysis, 2017, 7(1), 34-59.
    54. Qiao, B., et al., Single-atom catalysis of CO oxidation using Pt1/FeOx. Nature chemistry, 2011, 3(8), 634-641.
    55. Weon, S., et al., Environmental materials beyond and below the nanoscale: Single-atom catalysts. Acs Es&T Engineering, 2020, 1(2), 157-172.
    56. Hülsey, M.J., J. Zhang, and N. Yan, Harnessing the wisdom in colloidal chemistry to make stable single‐atom catalysts. Advanced Materials, 2018, 30(47), 1802304.
    57. Wang, J., et al., Fabrication of single‐atom catalysts with precise structure and high metal loading. Advanced Materials, 2018, 30(48), 1801649.
    58. Peng, Y., B. Lu, and S. Chen, Carbon‐supported single atom catalysts for electrochemical energy conversion and storage. Advanced Materials, 2018, 30(48), 1801995.
    59. Lai, W.H., et al., General π‐electron‐assisted strategy for Ir, Pt, Ru, Pd, Fe, Ni single‐atom electrocatalysts with bifunctional active sites for highly efficient water splitting. Angewandte Chemie International Edition, 2019, 58(34), 11868-11873.
    60. Yin, P., et al., Single cobalt atoms with precise N‐coordination as superior oxygen reduction reaction catalysts. Angewandte Chemie, 2016, 128(36), 10958-10963.
    61. Li, X., et al., Supported noble‐metal single atoms for heterogeneous catalysis. Advanced Materials, 2019, 31(50), 1902031.
    62. Zhang, H., et al., Single‐atom catalysts: emerging multifunctional materials in heterogeneous catalysis. Advanced Energy Materials, 2018, 8(1), 1701343.
    63. Wei, H., et al., Iced photochemical reduction to synthesize atomically dispersed metals by suppressing nanocrystal growth. Nature communications, 2017, 8(1), 1490.
    64. Leskelä, M. and M. Ritala, Atomic layer deposition chemistry: recent developments and future challenges. Angewandte Chemie International Edition, 2003, 42(45), 5548-5554.
    65. Liu, L. and A. Corma, Metal catalysts for heterogeneous catalysis: from single atoms to nanoclusters and nanoparticles. Chemical reviews, 2018, 118(10), 4981-5079.
    66. O’Neill, B.J., et al., Catalyst design with atomic layer deposition. Acs Catalysis, 2015, 5(3), 1804-1825.
    67. Yan, H., et al., Single-atom Pd1/graphene catalyst achieved by atomic layer deposition: remarkable performance in selective hydrogenation of 1, 3-butadiene. Journal of the American chemical society, 2015, 137(33), 10484-10487.
    68. Xiang, H., W. Feng, and Y. Chen, Single‐atom catalysts in catalytic biomedicine. Advanced Materials, 2020, 32(8), 1905994.
    69. Cui, X., et al., Bridging homogeneous and heterogeneous catalysis by heterogeneous single-metal-site catalysts. Nature Catalysis, 2018, 1(6), 385-397.
    70. Xi, J., et al., Synthesis strategies, catalytic applications, and performance regulation of single‐atom catalysts. Advanced Functional Materials, 2021, 31(12), 2008318.
    71. Wang, Y., D. Wang, and Y. Li, Rational design of single‐atom site electrocatalysts: from theoretical understandings to practical applications. Advanced Materials, 2021, 33(34), 2008151.
    72. Wang, X., et al., Regulation of coordination number over single Co sites: triggering the efficient electroreduction of CO2. Angewandte Chemie, 2018, 130(7), 1962-1966.
    73. Sichert, J.A., et al., Quantum size effect in organometal halide perovskite nanoplatelets. Nano letters, 2015, 15(10), 6521-6527.
    74. Rabouw, F.T. and C. de Mello Donega, Excited-state dynamics in colloidal semiconductor nanocrystals. Photoactive Semiconductor Nanocrystal Quantum Dots: Fundamentals and Applications, 2017, 1-30.
    75. Lee, J., et al., Size-controlled electron transfer and photocatalytic activity of ZnO–Au nanoparticle composites. The Journal of Physical Chemistry Letters, 2011, 2(22), 2840-2845.
    76. Jakub, Z., et al., Local structure and coordination define adsorption in a model Ir1/Fe3O4 single‐atom catalyst. Angewandte Chemie International Edition, 2019, 58(39), 13961-13968.
    77. Wang, L.-C., et al., Atomically dispersed golds on degradable zero-valent copper nanocubes augment oxygen driven Fenton-like reaction for effective orthotopic tumor therapy. Nature communications, 2022, 13(1), 7772.
    78. Cai, S., et al., Tumor‐Microenvironment‐Responsive Cascade Reactions by a Cobalt‐Single‐Atom Nanozyme for Synergistic Nanocatalytic Chemotherapy. Angewandte Chemie International Edition, 2022, 61(48), e202204502.
    79. Yan, R., et al., Nanozyme-based bandage with single-atom catalysis for brain trauma. ACS nano, 2019, 13(10), 11552-11560.
    80. Zhao, D., et al., Atomic site electrocatalysts for water splitting, oxygen reduction and selective oxidation. Chemical Society Reviews, 2020, 49(7), 2215-2264.
    81. Mao, J., et al., The synthesis of single-atom catalysts for heterogeneous catalysis. Chemical Communications, 2023.
    82. Xia, X., et al., 25th anniversary article: galvanic replacement: a simple and versatile route to hollow nanostructures with tunable and well‐controlled properties. Advanced Materials, 2013, 25(44), 6313-6333.
    83. Lucci, F.R., et al., Selective hydrogenation of 1, 3-butadiene on platinum–copper alloys at the single-atom limit. Nature communications, 2015, 6(1), 8550.
    84. Liu, W., et al., Highly-efficient RuNi single-atom alloy catalysts toward chemoselective hydrogenation of nitroarenes. Nature Communications, 2022, 13(1), 3188.
    85. Chen, Y. and J. Shi, Chemistry of mesoporous organosilica in nanotechnology: molecularly organic–inorganic hybridization into frameworks. Advanced Materials, 2016, 28(17), 3235-3272.
    86. Yang, G., et al., Degradability and clearance of inorganic nanoparticles for biomedical applications. Advanced Materials, 2019, 31(10), 1805730.
    87. Rengan, A.K., et al., In vivo analysis of biodegradable liposome gold nanoparticles as efficient agents for photothermal therapy of cancer. Nano letters, 2015, 15(2), 842-848.
    88. Wang, L., et al., Iron-engineered mesoporous silica nanocatalyst with biodegradable and catalytic framework for tumor-specific therapy. Biomaterials, 2018, 163, 1-13.
    89. Zhao, F., et al., H2O2-independent chemodynamic therapy initiated from magnetic iron carbide nanoparticle-assisted artemisinin synergy. RSC advances, 2021, 11(59), 37504-37513.
    90. Hou, S., et al., Tumor microenvironment responsive biomimetic copper peroxide nanoreactors for drug delivery and enhanced chemodynamic therapy. Chemical Engineering Journal, 2021, 416, 129037.
    91. Su, H., et al., Single atoms of iron on MoS2 nanosheets for N2 electroreduction into ammonia. Angewandte Chemie, 2020, 132(46), 20591-20596.
    92. Sun, S., Recent advances in chemical synthesis, self‐assembly, and applications of FePt nanoparticles. Advanced Materials, 2006, 18(4), 393-403.
    93. Hao, R., et al., Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Advanced materials, 2010, 22(25), 2729-2742.
    94. Chou, S.-W., et al., In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. Journal of the American Chemical Society, 2010, 132(38), 13270-13278.
    95. Shi, L., et al., An Acidity‐Unlocked Magnetic Nanoplatform Enables Self‐Boosting ROS Generation through Upregulation of Lactate for Imaging‐Guided Highly Specific Chemodynamic Therapy. Angewandte Chemie, 2021, 133(17), 9648-9658.
    96. Gao, J., et al., FePt@CoS2 yolk− shell nanocrystals as a potent agent to kill HeLa cells. Journal of the American Chemical Society, 2007, 129(5), 1428-1433.
    97. Choi, J.-s., et al., Biocompatible heterostructured nanoparticles for multimodal biological detection. Journal of the American Chemical Society, 2006, 128(50), 15982-15983.
    98. Page, S.E., W.A. Arnold, and K. McNeill, Terephthalate as a probe for photochemically generated hydroxyl radical. Journal of Environmental Monitoring, 2010, 12(9), 1658-1665.
    99. Gonzalez, D.H., et al., Terephthalate probe for hydroxyl radicals: yield of 2-hydroxyterephthalic acid and transition metal interference. Analytical Letters, 2018, 51(15), 2488-2497.
    100. Rana, A., et al., Cetyltrimethylammonium modified graphene as a clean swelling inhibitor in water-based oil-well drilling mud. Journal of Environmental Chemical Engineering, 2020, 8(4), 103802.
    101. Mohyaldinn, M.E., et al., Stability, Rheological Behavior, and pH Responsiveness of CTAB/HCl Acidic Emulsion: Experimental Investigation. ACS Omega, 2023.
    102. Kane, D.M., A. Micolich, and J. Rabeau, Nanotechnology in Australia: Showcase of Early Career Research. 2011: Pan Stanford Publishing.
    103. Si, R., et al., Self-organized monolayer of nanosized ceria colloids stabilized by poly (vinylpyrrolidone). The Journal of Physical Chemistry B, 2006, 110(12), 5994-6000.
    104. Graf, C., et al., A general method for the controlled embedding of nanoparticles in silica colloids. Langmuir, 2006, 22(13), 5604-5610.
    105. Lapeire, L., et al., Influence of grain size on the electrochemical behavior of pure copper. Journal of materials science, 2017, 52, 1501-1510.
    106. Gokcekaya, O., et al., Using HAADF-STEM for atomic-scale evaluation of incorporation of antibacterial Ag atoms in a β-tricalcium phosphate structure. Nanoscale, 2020, 12(31), 16596-16604.
    107. Sohlberg, K., et al., Insights into the physical chemistry of materials from advances in HAADF-STEM. Physical Chemistry Chemical Physics, 2015, 17(6), 3982-4006.
    108. Liu, Q. and Z. Zhang, Platinum single-atom catalysts: a comparative review towards effective characterization. Catalysis Science & Technology, 2019, 9(18), 4821-4834.
    109. Batson, P.E., N. Dellby, and O.L. Krivanek, Sub-ångstrom resolution using aberration corrected electron optics. Nature, 2002, 418(6898), 617-620.
    110. Maccagnano-Zacher, S., et al., Effects of tilt on high-resolution ADF-STEM imaging. Ultramicroscopy, 2008, 108(8), 718-726.
    111. Nath, D., F. Singh, and R. Das, X-ray diffraction analysis by Williamson-Hall, Halder-Wagner and size-strain plot methods of CdSe nanoparticles-a comparative study. Materials Chemistry and Physics, 2020, 239, 122021.
    112. Shah, R.M., et al., Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells. Colloids and Surfaces B: Biointerfaces, 2016, 140, 204-212.
    113. Shilpi, D., et al., Improved stability and enhanced oral bioavailability of atorvastatin loaded stearic acid modified gelatin nanoparticles. Pharmaceutical Research, 2017, 34, 1505-1516.
    114. Zhao, J., et al., Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis. European Journal of Pharmaceutics and Biopharmaceutics, 2018, 130, 39-47.
    115. Trisnanto, S.R., et al., Stearic acid-modified CuO coating metal surface with superhydrophobicity and anti-corrosion properties. J. Eng. Res, 2019, 2019, 63-75.
    116. Lei, Y., et al., Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression. Journal of Controlled Release, 2016, 232, 131-142.
    117. Teo, J., et al., A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo. Biomacromolecules, 2016, 17(7), 2337-2351.

    下載圖示
    2026-01-31公開
    QR CODE